L, L., A, P., A, d. T., C, D., M, E., Z, L., . . . I, D. (2020). Neospora caninum: A new class of biopharmaceuticals in the therapeutic arsenal against cancer. Journal for immunotherapy of cancer, 8(2), . https://doi.org/10.1136/jitc-2020-001242
Chicago Style (17th ed.) CitationL, Lantier, et al. "Neospora Caninum: A New Class of Biopharmaceuticals in the Therapeutic Arsenal Against Cancer." Journal for Immunotherapy of Cancer 8, no. 2 (2020). https://doi.org/10.1136/jitc-2020-001242.
MLA (9th ed.) CitationL, Lantier, et al. "Neospora Caninum: A New Class of Biopharmaceuticals in the Therapeutic Arsenal Against Cancer." Journal for Immunotherapy of Cancer, vol. 8, no. 2, 2020, https://doi.org/10.1136/jitc-2020-001242.
Warning: These citations may not always be 100% accurate.
